DAVID A SHAFRITZ, MD
Osteopathic Medicine in Bronx, NY
License number
New York 116115
Category
Osteopathic Medicine
Type
Gastroenterology
Address
Address
2
1300 Aecom - L.r.c. - Ullmann STE. 603, Bronx, NY 10461
4 Pheasant Run, Larchmont, NY 10538
4 Pheasant Run, Larchmont, NY 10538
Phone
(718) 430-2098
(718) 430-8975 (Fax)
(718) 430-8975 (Fax)
Personal information
See more information about DAVID A SHAFRITZ at radaris.comName
Address
Phone
New Rochelle, NY
4 Pheasant Run, Larchmont, NY 10538
Organization information
See more information about DAVID A SHAFRITZ at bizstanding.comDavid Shafritz MD
1300 Morris Park Ave, Bronx, NY 10461
Industry:
Internist
Phone:
(718) 430-2098 (Phone)
David Andrew Shafritz
Professional information
David A Shafritz, Bronx NY
Specialties:
Internal Medicine, Gastroenterology
Work:
Montefiore Medical Center
1300 Morris Park Ave, Bronx, NY 10461 Montefiore Medical Center
1825 Eastchester Rd, Bronx, NY 10461 MMC Medical Park at Eastchester
1575 Blondell Ave, Bronx, NY 10461
1300 Morris Park Ave, Bronx, NY 10461 Montefiore Medical Center
1825 Eastchester Rd, Bronx, NY 10461 MMC Medical Park at Eastchester
1575 Blondell Ave, Bronx, NY 10461
Education:
University of Pennsylvania(1966)
Dr. David A Shafritz, Bronx NY - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
Albert Einstein Livr Rsrch Cntr
1300 Morris Park Ave SUITE 625, Bronx 10461
(718) 430-2098 (Phone)
1300 Morris Park Ave SUITE 625, Bronx 10461
(718) 430-2098 (Phone)
Certifications:
Internal Medicine, 1979
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Perelman School of Medicine University of Pennsylvania
Graduated: 1966
University Of Maryland Medical Center
Massachusetts General Hospital
Perelman School of Medicine University of Pennsylvania
Graduated: 1966
University Of Maryland Medical Center
Massachusetts General Hospital
Non-A, Non-B. Hepatitis, Virus, Methods Of Identification Purification, Characterization, Diagnosis And Immunization
US Patent:
4870026, Sep 26, 1989
Filed:
Feb 8, 1984
Appl. No.:
6/577324
Inventors:
Jack Wands - Waban MA
David Shafritz - Larchmont NY
David Shafritz - Larchmont NY
Assignee:
The General Hospital Corporation - Boston MA
The Albert Einstein College of Medicine of Yeshiva University - Boston MA
The Albert Einstein College of Medicine of Yeshiva University - Boston MA
International Classification:
G01N 3353, A61K 3942
US Classification:
436548
Abstract:
A purified form of a DNA virus which has the following characteristics: molecular weight greater than 2. times. 10. sup. 6 Daltons; substantial immunoreactivity towards an anti-HBsAg monoclonal antibody obtained from cell line ATCC HB 8058; substantially no immunoreactivity towards an anti-HBsAg monoclonal antibody obtained from cell line ATCC CRL 8018; concentration dependent immunoreactivity towards polyclonal IgG anti-HBsAg antibodies, which increases with increased concentration of said DNA virus; discrete particulate form when observed by immunoelectron microscopy in the presence of IgM antibodies from cell line ATCC HB 8058; the DNA of said virus showing hybridization with DNA from hepatitis B viral DNA; and said DNA virus showing, in chimpanzees, infectivity having the characteristics of non A, non B hepatitis.
Diagnostic Test For Hepatitis B Virus
US Patent:
4562159, Dec 31, 1985
Filed:
Mar 31, 1981
Appl. No.:
6/249369
Inventors:
David A. Shafritz - Larchmont NY
Assignee:
Albert Einstein College of Medicine, A Division of Yeshiva Univ. - Bronx NY
International Classification:
C12N 1500, G01N 3350
US Classification:
436501
Abstract:
A method and test kit are disclosed for detecting the presence of hepatitis B virus in a test specimen containing at least a portion of the DNA of the virus. A test reagent comprises cloned hepatitis B virus-DNA that has been repurified by treatment with a restriction enzyme and labelled to high specific activity with a radioactive label. The sample to be tested is fixed to a solid matrix, incubated in the presence of the test reagent under hybridization conditions and detected by hybridization to the labelled DNA probe. The uncombined HBV-DNA (labelled) is removed from the substrate, and the hybridized HBV-DNA determined by scintillation counting or by autoradiography of the substrate.
Method Of Suppressing Cell Growth By Immunotherapy
US Patent:
4714613, Dec 22, 1987
Filed:
Sep 30, 1982
Appl. No.:
6/428653
Inventors:
Daniel Shouval - Jerusalem, IL
David A. Shafritz - Larchmont NY
Jack R. Wands - Waban MA
David A. Shafritz - Larchmont NY
Jack R. Wands - Waban MA
Assignee:
The Albert Einstein College of Medicine of Yeshiva University - New York NY
The General Hospital Corporation - Boston MA
The General Hospital Corporation - Boston MA
International Classification:
A61K 3942, A61K 3900, C12P 2100, C12Q 102
US Classification:
424 86
Abstract:
A selective method of suppressing the growth of cells which express a viral antigen on the surface thereof, which comprises administering to the cells a growth suppressing amount of a monoclonal antibody against said viral antigen, especially a method of suppressing the growth of hepatocytes or hepatoma cells persistently infected with HBsAg which comprises administering to the cells a growth suppressing or lethal amount of a complement fixing monoclonal IgM or IgG. sub. 2a antibody against HBsAg.